| Autor: |
Loriot Y; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; PRISM, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr., Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France. maud.kamal@gustaveroussy.fr., Syx L; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France., Nicolle R; Université Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM, U1149, CNRS, ERL 8252, F-, 75018, Paris, France., Dupain C; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France., Menssouri N; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Duquesne I; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Lavaud P; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Nicotra C; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France., Ngocamus M; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France., Lacroix L; Biopath department, Gustave Roussy, Villejuif, France., Tselikas L; Department of interventional radiology, Gustave Roussy, Villejuif, France., Crehange G; Department of Radiothérapie, Institut Curie, 75005 Paris & 92210 Saint-Cloud, Paris, France., Friboulet L; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; PRISM, Gustave Roussy, Villejuif, France., Castel-Ajgal Z; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France., Neuzillet Y; Department of Urology, Foch Hospital, Suresnes, France., Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France., Beuzeboc P; Department of Urology, Foch Hospital, Suresnes, France., Marret G; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France., Gutman T; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France., Wong J; Department of Genetics, Institut Curie, 75005, Paris, France., Radvanyi F; UMR144, Institut Curie, 75005, Paris, France., Dureau S; Biometry unit, direction of clinical research, Institut Curie, 75005, Paris, France., Scoazec JY; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Biopath department, Gustave Roussy, Villejuif, France., Servant N; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France., Allory Y; Department of Pathology, Institut Curie, PSL Research University, 75005, Paris, France., Besse B; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Andre F; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; PRISM, Gustave Roussy, Villejuif, France., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France., Massard C; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France., Bieche I; Department of Genetics, Institut Curie, 75005, Paris, France.; INSERM U1016, Faculty of Pharmaceutical and Biological Sciences, Université Paris Cité, Paris, France. |
Full text from SpringerLink